Inventor
Evangelos Aktoudianakis
Inventor
Redwood City, CA, US
Overview
Patents· 11 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations30%
C07DHeterocyclic compounds30%
A61KPreparations for medical, dental or toiletry purposes15%
C07BGeneral methods of organic chemistry12%
C07CAcyclic or carbocyclic compounds6%
C07KPeptides6%
PatentTitleYear
10,899,735PD-1/PD-L1 inhibitors202110,774,071PD-1/PD-L1 inhibitors202010,710,986PD-1/PD-L1 inhibitors202010,442,804Compounds for the treatment of hepatitis B virus infection201910,285,990Toll like receptor modulator compounds201910,100,052Compounds for the treatment of hepatitis B virus infection201810,017,501Benzimidazole derivatives as bromodomain inhibitors20189,670,205'Toll like receptor modulator compounds'20179,458,145'Benzimidazole derivatives as bromodomain inhibitors'20169,255,089'Benzimidazolone derivatives as bromodomain inhibitors'20167,998,950'Antiviral compounds'2011Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2011–2021Patents assigned to GILEAD SCIENCES INC (10)· patent assignee history
2011–2016Based in San Mateo, CA, US· patent location history
2017–2021Based in Redwood City, CA, US· patent location history
2020Based in Foster City, CA, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| GILEAD SCIENCES INC | 10 | 2011–2021 |
Locations
| Location | Patents | Span |
|---|---|---|
| Redwood City, California, US | 7 | 2017–2021 |
| San Mateo, California, US | 3 | 2011–2016 |
| Foster City, California, US | 1 | 2020 |